The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks you Sportstrader. Orph bit starts around 1:05:00
My key takeaways:
Themis sold to Merck for an estimated £100m-£500m, Imutex is a very similar company, and probably worth more than that. The Merck deal came out of nowhere a few days ago, and may open up other options for monetising Imutex. If sold (Novartis mentioned several times) cash would be returned to holders, probably as a dividend.
ORPH now have no fewer than 4 transformational projects, each one of them credible and active. Any one of them succeeding would likely result in a substantially higher valuation.
Really glad I’ve invested - very positive interview
Thank You Sportstrader, much appreciated.
Unfortunately I missed the webinar as I read an earlier post stating it started t 19:30. I must DMOR. From the info filtering through on the board it all sounded very positive, I am looking forward to watching the interview. How long does it usually take for Proactive Investors to load the webinar up to their website?
I love how relaxed and confidently CF speaks about the company. He definitely needs media exposure on the tv. Hopefully that is included in his press launch and not just newspapers and web.
Is there a link that works?
Cathal emphasising big press launch of antibody testing in coming week to 10 days time.
on YouTube .. /watch?v=RWNHn4T93BY